Methods of treating or ameliorating metabolic disorders using binding proteins for gastric inhibitory peptide receptors (GIPR) in combination with GLP-1 agonists

摘要

Methods of treating metabolic diseases and disorders using antigen binding proteins specific for GIPR polypeptides are provided. In various embodiments, the metabolic disease or disorder is type 2 diabetes, obesity, dyslipidemia, elevated glucose levels, elevated insulin levels, and diabetic neuropathy. In certain embodiments, the antigen binding protein is administered in combination with a GLP-1 receptor agonist.